Want to be a guest on The Platform podcast? Learn more and submit your application today.
Virtual training and education has never been more important. Even before COVID-19, Osso VR identified a training gap for surgeons, nurses, OR staff, and surgical sales reps in North America. They created a technology to address the surgical training gap which uses virtual reality to improve patient outcomes, increase the adoption of higher-value medical technologies and provide access to critical education globally.
Read MoreOn today's episode of The Platform, we learn about angel and venture investing in the life sciences sector. Randy Thompson, Chairman and CEO of Valhalla Private Capital, gives us a window into the inner workings of venture capital funds and also provides listeners with valuable advice for fundraising in today's business environment.
Read MoreIn this episode of The Platform, Erica chats with Total Brain, a biotech company that has developed tech that shows improvements in mental health and fitness through brain-based self-awareness and training.
Read MoreIn this episode of The Platform, Lise Pape, Founder and Managing Director of Walk With Path joins us to discuss how this new laser shoe technology is paving the way for people living with Parkinson’s Disease. As the company begins to seek investment, you’ll hear about the concept, the numbers, and the opportunity.
Read MoreGlobally, the Coalition for Epidemic Preparedness Innovations (CEPI) has invested more than $23 million US towards the development of a vaccine for COVID-19 and, as of now, it is expected that around 20 companies have potential medicines in various stages of development, with at least four existing medicines now in late phase clinical trials. Meanwhile there are around fifty projects exploring a variety of vaccine technologies, many of them industry/academia collaborations, and the most advanced entering early phase clinical trials... But what does this all mean? And when can we expect to see a vaccine? We chat with Dr. Beatnice Setnik of Altasciences to uncover the timeline and process in getting a vaccine to market.
Read MoreGlobally, the Coalition for Epidemic Preparedness Innovations (CEPI) has invested more than $23 million US towards the development of a vaccine for COVID-19 and, as of now, it is expected that around 20 companies have potential medicines in various stages of development, with at least four existing medicines now in late phase clinical trials. Meanwhile there are around fifty projects exploring a variety of vaccine technologies, many of them industry/academia collaborations, and the most advanced entering early phase clinical trials... But what does this all mean? And when can we expect to see a vaccine? We chat with Dr. Beatnice Setnik of Altasciences to uncover the timeline and process in getting a vaccine to market.
Read MoreThe Go-To Podcast for Deal Makers in Life Sciences & Pharma. In this episode, Adam and Erica are joined by Jim Gale, the Founding Partner and Managing Director of Signet Healthcare Partners. He talks about the state of growth capital in the healthcare industry and how to access it.
Read MoreWe are flying high off the announcement of our brand new website, but the fun doesn’t end there!. As promised, Sosna + Co has big things on the way. We are so excited to announce our very own podcast, The Platform! The Platform will bring together thought leaders and industry experts to discuss the ever-changing life science industry. We will bring you up to speed on current events, educated on the inner workings of the industry and keep you well ahead of the curve on trends in the life science industry. The best part? Episode 1 launches tomorrow! Read on to learn about what’s in store and where you can have a listen!
Read MoreThey say hindsight is 20/20, but given the start of a new decade, Sosna + Co is starting the year looking forward: growth for our clients, exciting opportunities, and a fresh, new brand!
Read More
